ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest mRNA news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks mRNA across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Slovak-founded biotech startup Sensible Biotechnologies secured $47 million (€42 million) in financing to develop its cell-based mRNA platform. The round includes Series A funding led by Oxford Science Enterprises and up to $20 million in public support from the Slovak government and the European Union.
Summaries by ByteBrief